Project Grant R16AI177410
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$177K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Bowling Green, KY, USA
Similar Awards
This $256,995 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to quantitatively link host cell mutations to phenotypic traits of the intracellular pathogen Legionella pneumophila. The research aims to develop a generalizable strategy for identifying host proteins that promote or restrict the growth of intracellular pathogens, using optical sequencing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $910,860 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The project aims to characterize a cell-surface signaling system employed by the bacterial pathogen Legionella, which plays a central role in promoting the integrity of Legionella's replication vacuole. This work will define a molecular surveillance system used by Legionella, a causative...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $143,784 to The Johns Hopkins University to conduct research characterizing how the bacterium Legionella pneumophila inhibits host cell translation. The primary objectives are to: 1) determine the mechanism of action of the Legionella effector protein SidL, which inhibits translation, and 2) perform a...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID), supports research to decipher how the CAS2 ribonuclease protein from the bacterium Legionella pneumophila (LP) non-canonically controls the organism's thermal tolerance and virulence. The $456,000 award, valid from July 2024 to May 2026, is being provided to Northwestern University to conduct this research under the NIAID's Allergy and Infectious Diseases Research program (CFDA 93.855)....
This $147,712 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research will fund research investigating how the Mycobacterium tuberculosis (MTB) protein Rv1075c interacts with the host's histone methyltransferase complexes to influence gene expression and promote MTB infection. The key objectives are to define how histone methylation changes at innate immune genes during MTB infection, and to examine how...
This $1,361,909 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to identify and characterize genes required for the cytosolic survival of the bacterial pathogen Listeria monocytogenes. The key objectives are to: 1) Understand how host cells recognize and respond to bacteria in the cytosol, and how cytosolic pathogens adapt to survive in this environment,...
The federal Project Grant award in the amount of $791,864.00, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to identify the molecular factors controlling chromatin organization and gene regulation in the malaria parasite Plasmodium falciparum, with a specific focus on long non-coding RNAs (lncRNAs). The research aims to elucidate the importance of lncRNAs in parasite...
This $462,500 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to decipher the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics. The award will fund a 5-year research project led by St. Jude Children's Research Hospital to comprehensively characterize bacterial heterogeneity under antibiotic treatment and identify the...
This federal Project Grant award of $784,217.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to characterize how cellular death programs contribute to both protective and injurious inflammation during bacterial infections. The research will utilize human cells, murine genetics, and knockdown/knockout strategies to understand how components of cell death signaling, such as...
This $2,147,862 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate how Epstein-Barr virus (EBV) infection alters the 3D chromatin structure and gene expression in B cells, driving the development of EBV-associated lymphomas. The research, conducted by The Wistar Institute of Anatomy and Biology in Philadelphia, aims to identify the key...